Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BKM120 in Advanced Differentiated Thyroid Cancers
NCT01830504Phase 2Unknown
- Sponsor
- Hospices Civils de Lyon
- Start
- Apr 2013
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of buparlisib in Follicular thyroid cancer (FTC), Poorly differentiated thyroid cancer (PDTC), sponsored by Hospices Civils de Lyon. Status: unknown.
02
Drugs
buparlisib
03
Conditions
Follicular thyroid cancer (FTC)Poorly differentiated thyroid cancer (PDTC)
Beyond the preview
Go deeper on NCT01830504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01830504.